Equities research analysts forecast that Israel Chemicals (NYSE:ICL) will post earnings per share (EPS) of $0.07 for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Israel Chemicals’ earnings. Israel Chemicals posted earnings per share of $0.05 in the same quarter last year, which would suggest a positive year over year growth rate of 40%. The company is expected to report its next earnings results before the market opens on Wednesday, May 9th.
According to Zacks, analysts expect that Israel Chemicals will report full year earnings of $0.34 per share for the current fiscal year, with EPS estimates ranging from $0.30 to $0.37. For the next year, analysts anticipate that the business will post earnings of $0.37 per share, with EPS estimates ranging from $0.35 to $0.38. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that follow Israel Chemicals.
Israel Chemicals (NYSE:ICL) last announced its quarterly earnings results on Wednesday, February 14th. The basic materials company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.03. Israel Chemicals had a net margin of 6.72% and a return on equity of 13.88%. The company had revenue of $1.36 billion for the quarter. During the same quarter in the prior year, the firm posted $0.09 EPS. The company’s revenue for the quarter was up 1.7% on a year-over-year basis.
Several equities research analysts recently weighed in on ICL shares. TheStreet upgraded shares of Israel Chemicals from a “c+” rating to a “b-” rating in a research report on Friday, March 9th. Zacks Investment Research cut shares of Israel Chemicals from a “buy” rating to a “hold” rating in a research report on Thursday, March 8th. Citigroup upgraded shares of Israel Chemicals from a “neutral” rating to a “buy” rating in a research report on Wednesday, March 21st. Finally, ValuEngine upgraded shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $5.00.
ICL traded down $0.03 during trading hours on Tuesday, hitting $4.36. The company’s stock had a trading volume of 78,107 shares, compared to its average volume of 177,912. Israel Chemicals has a 12 month low of $3.85 and a 12 month high of $4.95. The stock has a market capitalization of $5,720.04, a PE ratio of 14.06 and a beta of 1.01. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.64 and a current ratio of 1.17.
A number of hedge funds and other institutional investors have recently bought and sold shares of ICL. Bank of New York Mellon Corp boosted its stake in Israel Chemicals by 5.5% during the third quarter. Bank of New York Mellon Corp now owns 1,379,180 shares of the basic materials company’s stock worth $6,124,000 after buying an additional 71,750 shares during the period. Russell Investments Group Ltd. boosted its stake in Israel Chemicals by 117.2% during the third quarter. Russell Investments Group Ltd. now owns 88,128 shares of the basic materials company’s stock worth $390,000 after buying an additional 47,562 shares during the period. JPMorgan Chase & Co. boosted its stake in Israel Chemicals by 516.9% during the third quarter. JPMorgan Chase & Co. now owns 168,346 shares of the basic materials company’s stock worth $748,000 after buying an additional 141,059 shares during the period. Citadel Advisors LLC purchased a new position in Israel Chemicals during the third quarter worth $214,000. Finally, Swiss National Bank boosted its stake in Israel Chemicals by 0.7% during the fourth quarter. Swiss National Bank now owns 1,966,371 shares of the basic materials company’s stock worth $7,993,000 after buying an additional 13,758 shares during the period. 7.79% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: This story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/15/brokerages-expect-israel-chemicals-icl-will-announce-earnings-of-0-07-per-share.html.
Israel Chemicals Company Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Get a free copy of the Zacks research report on Israel Chemicals (ICL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.